Advertisement

Parathyroid Adenoma Which Was Negative on Tc99m-MIBI Scintigraphy and Considered as Paratracheal Lymphadenopathy on Other Imaging Studies

  • Meral Mert
Chapter

Abstract

Surgery is the most important treatment method in patients with primary hyperparathyroidism. Imaging studies for localization of parathyroid adenoma should be performed in all patients with hyperparathyroidism before surgical intervention. Tc99m scintigraphy, neck ultrasonography, and neck magnetic resonance imaging (MRI) are the most common imaging modalities used for the localization of a parathyroid adenoma. Atypical localization of parathyroid adenoma and multiple gland disease are the most important causes of persistent disease and redo surgery. We aimed to introduce a case of primary hyperparathyroidism with the presence of double adenoma. In our case, the second adenoma was mistakenly interpreted as lymphadenopathy in the preoperative imaging studies. The lesion has been confirmed as parathyroid adenoma in the final histopathologic examination.

Therefore, multiple or atypical localized parathyroid adenoma should be considered in all patients to be operated.

Keywords

Parathyroid adenoma Double adenoma Neck MRI Tc99m-MIBI scintigraphy Lymphadenomegaly 

Notes

Acknowledgment

We would like to thank Dr. Deniz Guzey and Cevher Akarsu for their valuable contribution to the surgical management of the patient.

References

  1. 1.
    Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease. Ann Surg. 1992;215:300.CrossRefGoogle Scholar
  2. 2.
    Udelsman R, Pasieka JL, Sturgeon C, Young JE, Clark OH. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Clin Endocrinol Metab. 2009;94:366.  https://doi.org/10.1210/jc.2008-1761.CrossRefGoogle Scholar
  3. 3.
    Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3561.  https://doi.org/10.1210/jc.2014-1413.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131:149.CrossRefGoogle Scholar
  5. 5.
    Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J, et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg. 2008;248:420.  https://doi.org/10.1097/SLA.0b013e3181859f71.CrossRefPubMedGoogle Scholar
  6. 6.
    Chiu B, Sturgeon C, Angelos P. What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy. Surgery. 2006;140:418.  https://doi.org/10.1016/j.surg.2006.03.021.CrossRefPubMedGoogle Scholar
  7. 7.
    Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, et al. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg. 2007;142:381.  https://doi.org/10.1001/archsurg.142.4.381.CrossRefPubMedGoogle Scholar
  8. 8.
    Friedman K, Somervell H, Patel P, Melton GB, Garrett-Mayer E, Dackiw AP, et al. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery. 2004;136:1199.  https://doi.org/10.1016/j.surg.2004.06.047.CrossRefPubMedGoogle Scholar
  9. 9.
    Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084.  https://doi.org/10.2967/jnumed.107.040428.CrossRefPubMedGoogle Scholar
  10. 10.
    Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med. 2004;45:40.PubMedGoogle Scholar
  11. 11.
    Kobylecka M, Płazińska MT, Chudziński W, Fronczewska-Wieniawska K, Mączewska J, Bajera A, et al. Comparison of scintigraphy and ultrasound imaging in patients with primary, secondary and tertiary hyperparathyroidism - own experience. J Ultrason. 2017;17:17–22.  https://doi.org/10.15557/JoU.2017.0002.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Sung JY. Parathyroid ultrasonography: the evolving role of the radiologist. Ultrasonography. 2015;34:268–74.  https://doi.org/10.14366/usg.14071.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, et al. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun. 2003;24:755–62.CrossRefGoogle Scholar
  14. 14.
    Kluijfhout WP, Vriens MR, Valk GD, Barth RE, Borel Rinkes IH, de Keizer B. 18F-Fluorocholine PET–CT enables minimal invasive parathyroidectomy in patients with negative sestamibi SPECT–CT and ultrasound: a case report. Int J Surg Case Rep. 2015;13:73–5.  https://doi.org/10.1016/j.ijscr.2015.06.012.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Lebastchi AH, Aruny JE, Donovan PI, Quinn CE, Callender GG, Carling T, et al. Real-time super selective venous sampling in remedial parathyroid surgery. J Am Coll Surg. 2015;220:994.  https://doi.org/10.1016/j.jamcollsurg.2015.01.004.CrossRefPubMedGoogle Scholar
  16. 16.
    Gawrychowski J, Buła G. Imaging diagnostics for primary hyperparathyroidism. Endokrynol Pol. 2013;64:404–8.  https://doi.org/10.5603/EP.2013.0024.CrossRefPubMedGoogle Scholar
  17. 17.
    Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, et al. 18F fluorocholine PET/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study. Radiology. 2017;284(2):460–7.  https://doi.org/10.1148/radiol.2016160768.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Meral Mert
    • 1
  1. 1.Department of Endocrinology and MetabolismBakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University (SBÜ)İstanbulTurkey

Personalised recommendations